← Leaderboards
Avinash Das Sahu
Dana-Farber Cancer Inst
$955,886
Attributed
$955,886
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $249K · FY2020–25$250K$187.5K$125K$62.5K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$955,886 · 2
By mechanism
R00$715,810 · 1
K99$240,076 · 1
Top collaborators
No co-investigators on record.
Most similar at Dana-Farber Cancer Inst
Same institution · by research overlap
- Kenneth C Anderson$25,995,373
- Matthew L Freedman$13,331,420
- Jon C Aster$20,769,931
- Alejandro Gutierrez$7,788,333
- Frank C Kuo$2,294,788
Others in their field
Other Emerging Leaders on “Cell Line”
- Chani Eduard · Precision Bioservices, Inc.$19,909,203
- Stacey Lynn Clardy · Utah State Higher Education System--University Of Utah$15,093,619
- Laura Scheinfeldt · Coriell Institute For Medical Research$12,753,931
- Barbara Burtness · Yale University$11,235,253
- Olga Petrova · Suny At Binghamton$9,956,488
- James Dale Berry · Brigham And Women'S Hospital$9,819,674
Research focus
Cell LineCd8b1 GeneAftercareAdvanced Malignant NeoplasmAdvisory CommitteesAntineoplastic AgentsAreaArtificial IntelligenceAntibodiesAwardAntigen PresentationBiologicalBiological MarkersBiologyBraf GeneCancer CellCancer Clinical TrialCancer ImmunotherapyCancer PatientCancer TherapyCancer TypeCareerCareer DevelopmentClinical Data
Grant awards (5)
Identifying drug synergistic with cancer immunotherapy$249,000
R00 · FY2025 · CA · contact PI
Identifying drug synergistic with cancer immunotherapy$217,810
R00 · FY2024 · CA · contact PI
Identifying drug synergistic with cancer immunotherapy$249,000
R00 · FY2023 · CA · contact PI
Identifying drug synergistic with cancer immunotherapy$120,038
K99 · FY2021 · CA · contact PI
Identifying drug synergistic with cancer immunotherapy$120,038
K99 · FY2020 · CA · contact PI